Mirscience Therapeutics

Booth 1751
São Paulo, São Paulo, Brazil
Mirscience is a data driven company that through its platform develops miRNA therapies focusing on diseases that affect longevity. Today, with two assets in its pipeline focused on diseases that affect skeletal muscle, such as sarcopenia and cachexia associated with cancer. Our most advanced molecule, called MT-29 blocks the two targets responsible for muscle atrophy, increasing mass and strength by 21%.